Searchable abstracts of presentations at key conferences in endocrinology

ea0081ep402 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Bariatric Surgery in Type 1 Diabetes patients: a single centre study

Chopra Tanya , Wills Alice , Kavvoura Foteini

Background: Bariatric surgery significantly aids weight loss, improves glycaemic control and/or induces remission in Type 2 Diabetes patients. However, the impact of bariatric surgery in Type 1 diabetes (T1D) patients is less well-understood. With an increasing prevalence of obesity within the T1D population, it is important to identify whether bariatric surgery improves glycaemic control and prevents future complications.Aim: To evaluate the effect on B...

ea0090ep1162 | Late Breaking | ECE2023

Can we predict medical treatment failure in Graves’ disease? 4-year follow-up data in a single centre

Leonidas Liarakos Alexandros , Foka Anna , Mohamed Ahmed , Kavvoura Foteini

Background: GravesÂ’ disease (GD) is the commonest cause of primary hyperthyroidism in iodine-sufficient areas. First-line treatment is a 12-18 month course of anti-thyroid drugs (ATD). However, around 50% of GD patients will relapse, requiring further assessment and definitive treatment with radioactive iodine or thyroidectomy. Identifying risk factors that predict relapse or treatment failure after stopping ATD is important in guiding management. Several risk factors hav...

ea0094p134 | Thyroid | SFEBES2023

Identifying risk factors that predict medical treatment failure in Graves’ disease: a 4-year follow-up study in a single centre

Liarakos Alexandros , Foka Anna , Mohamed Ahmed , Kavvoura Foteini

Background: GravesÂ’ disease (GD) is the commonest cause of primary hyperthyroidism. First-line treatment involves 12-18 months of anti-thyroid drugs (ATD). Subsequently, around 50% of patients will relapse, requiring definitive treatment. Identifying risk factors that predict relapse or treatment failure can guide management. We aimed to explore risk factors that identify patients at high risk of relapse or medical treatment failure, to allow prioritisati...